Ending Cancer: “Canary” and Microscopic Velcro

cancer_cellEnding terminal illness is one of the hallmarks of the 21st century, with advances being made all the time. In recent years, efforts have been particularly focused on findings treatments and cures for the two greatest plagues of the past 100 years – HIV and cancer. But whereas HIV is one of the most infectious diseases to ever be observed, cancer is by far the greater killer. In 2008 alone, approximately 12.7 million cancers were diagnosed (excluding non-invasive cancers) and 7.6 million people died of cancer worldwide.

Little wonder then why so much time and energy is dedicated to ending it; and in recent years, a number of these initiatives have begun to bear fruit. One such initiative comes from the Mayo Clinic, where researchers claim they have developed a new type of software that can help classify cancerous lung nodules noninvasively, thus saving lives and health care costs.

lung-cancer-treatmentIt’s called Computer-aided Nodule Assessment and Risk Yield, or Canary, and a pilot study of the software recently appeared in the April issue of the Journal of Thoracic Oncology. According to the article, Canary uses data from high-resolution CT images of a common type of cancerous nodule in the lung and then matches them, pixel for pixel, to one of nine unique radiological exemplars. In this way, the software is able to make detailed comparisons and then determine whether or not the scans indicate the presence of cancer.

In the pilot study, Canary was able to classify lesions as either aggressive or indolent with high sensitivity, as compared to microscopic analyses of the lesions after being surgically removed and analyzed by lung pathologists. More importantly, it was able to do so without the need for internal surgery to allow a doctor to make a visual examination. This not only ensures that a patient could receive and early (and accurate) diagnosis from a simple CT scan, but also saves a great deal of money by making surgery unnecessary.

velcroAs they say, early detection is key. But where preventative medicine fails, effective treatments need to be available. And that’s where a new invention, inspired by Velcro comes into play. Created by researchers at UCLA, the process is essentially a refined method of capturing and analyzing rogue cancer cells using a Velcro-like technology that works on the nanoscale. It’s called NanoVelcro, and it can detect, isolate, and analyze single cancer cells from a patient’s blood.

Researchers have long recognized that circulating tumor cells play an important role in spreading cancer to other parts of the body. When the cells can be analyzed and identified early, they can offer clues to how the disease may progress in an individual patient, and how to best tailor a personalized cancer treatment. The UCLA team developed the NanoVelcro chip (see above) to do just that, trap individual cancer cells for analysis so that early, non-invasive diagnosis can take place.

NanoVelcro-deviceThe treatment begins with a patient’s blood being pumped in through the NanoVelcro Chip, where tiny hairs protruding from the cancer cells stick to the nanofiber structures on the device’s surface. Then, the scientists selectively cut out the cancer cells using laser microdissection and subject the isolated and purified cancer cells to single cell sequencing. This last step reveals mutations in the genetic material of the cells and may help doctors personalize therapies to the patient’s unique form of cancer.

The UCLA researchers say this technology may function as a liquid biopsy. Instead of removing tissue samples through a needle inserted into a solid tumor, the cancer cells can be analyzed directly from the blood stream, making analysis quicker and easier. They claim this is especially important in cancers like prostate, where biopsies are extremely difficult because the disease often spreads to bone, where the availability of the tissue is low. In addition, the technology lets doctors look at free-floating cancer cells earlier than they’d have access to a biopsy site.

Already, the chip is being tested in prostate cancer, according to research published in the journal Advanced Materials in late March. The process is also being tested by Swiss researchers to remove heavy metals from water, using nanomaterials to cling to and remove impurities like mercury and heavy metals. So in addition to assisting in the war on cancer, this new technology showcases the possibilities of nantechnology and the progress being made in that field.

Sources: news.cnet.com, fastcoexist.com

The Future is Here: Blood Monitoring Implants!

nanorobot1

The realm of nanotechnology, which once seemed like the stuff of science fiction, is getting closer to realization with every passing year. And with all the innovations taking place in tiny-scale manufacturing, molecular research, and DNA structures, we could be looking at an age where tiny machines regulate our health, construct buildings, assemble atomic structures, and even contain enough hardware to run complex calculations.

One such innovation was announced back in March by the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, where researchers created the world’s smallest medical implant capable of monitoring critical chemicals in the blood. Measuring a mere 14mm in length, the device is capable of measuring up to five indicators, like proteins, glucose, lactate, ATP, and then transmit this information to a smartphone via Bluetooth.

implantable-sensor-640x353

In short, it is capable of providing valuable information that may help track and prevent heart attacks and monitor for indications of harmful conditions, like diabetes. Each sensor is coated with an enzyme that reacts with blood-borne chemicals to generate a detectable signal, and is paired with a wearable battery that provides the 100 milliwatts of power that the device requires by wireless inductive charging through the skin.

For patient monitoring, such a device has so many useful applications that it is likely to become indispensable, once introduced. In cancer treatment for example, numerous blood tests are often required to calibrate treatments according the to the patient’s particular ability to break down and excrete drugs. And since these parameters often change due the patient’s reaction to said treatments, anything that can provide up-to-the-minute monitoring will spare the patient countless invasive tests.

nanotech-2

In addition, in cases of heart attacks, the signs are visible in the hours before the event occurs. This occurs when fatigued or oxygen-starved muscle begins to break down, releasing fragments of the heart-specific smooth muscle protein known as troponin. If this protein can be detected before disruption of the heart rhythm begins, or the actual attack, lifesaving preemptive treatment can be initiated sooner.

At the moment, the sensors are limited by the number of sensors they hold. But there is no theoretical limit to how any sensors each implant can hold. In the future, such a device could be equipped with electronics that could monitor for strokes, blood clots, high cholesterol, cancer cells, HIV, parasites, viruses, and even the common cold (assuming such a thing continues to exist!) Just think about it.

You’re going about your daily activities when suddenly, you get a ringtone that alerts you that you’re about to experience a serious a health concern. Or maybe that the heavy lunch you just ate raised the level of LDL cholesterol in your bloodstream to an unwanted level. Tell me, on a scale of one to ten, how cool would that be?

Source: Extremetech.com

The Future of Medicine: The Breathalyzer Cancer Test

cancer_cellAs any medical practitioners will tell you, when it comes to cancer, early detection is key. And interestingly enough, there are a number of ways to do this. In addition to visual identification (i.e. change in skin pigment), or feel (i.e. noticing lumps), there is also the means of olfactory detection. Apparently, on top of its many other noticeable effects, cancer emits a smell which can lead to early detection and treatment.

Over the years, a great deal of anecdotal and clinical research has shown that dogs are capable of sniffing out cancer in patients. Building on this knowledge, a group of scientists from Israel and China and working at Technion (the Israel Institute of Technology) have developed a stomach-cancer-sniffing device made out of nanomaterials that essentially works the same way as a breathalyzer.

Cancer patientsIn an initial screening test, the device was used on 130 patients and was over 90% accurate in detecting not only the existence of cancer, but determining what stage it was in. Compared to conventional methods, which involves inserting a flexible tube that is inserted through the patient’s nose and into their digestive system, this test is far less invasive and unpleasant.

endoscopy 2What’s more, this process – known as endoscopy – is quite expensive, making a comparatively cheap breathalyzer even more attractive to both doctor’s and patients. And of course, this test is generally used when the patient begins showing signs of being in an advanced stage of cancer development, and is therefore not part of an early detection regimen.

In an interview with the British Journal of Cancer, Professor Hossam Haick, lead researcher from the Technion, desribed the benefits of their new device:

The promising findings from this early study suggest that using a breath test to diagnose stomach cancers, as well as more benign complaints, could be a future alternative to endoscopies… Nevertheless, these results are at an early stage and support the concept of a breath test to detect stomach cancers but further validations are needed… But if found to be accurate enough, the nanomaterial breath test presents a new possibility for screening a population for stomach cancer, which would hopefully lead to earlier diagnosis of the disease.

cancer_breathalyserIn an interview with the Guardian, Kate Law, the director of clinical research at Cancer Research UK, said the test could lead to earlier detection of stomach cancer, which could save lives:

The results of this latest study are promising – although large-scale trials will now be needed to confirm these findings. Only one in five people are able to have surgery as part of their treatment as most stomach cancers are diagnosed at stages that are too advanced for surgery. Any test that could help diagnose stomach cancers earlier would make a difference to patients’ long-term survival.

Naturally, Professor Haick admitted that more testing is needed before this can become a regular practice, but both he and his staff are encouraged by their results thus far. What’s more, they clearly have the support of many doctors in the field who see this test as an effective and preferable means of diagnosing cancer over conventional methods.

So for intents and purposes, it would not be farfetched to imagine that during your a trip to see your doctor, he or she might tell you to insert a tube into your mouth and blow, just to make sure you stomach tissue was healthy, pink, and cancer free!

Sources: fastcoexist.com, guardian.co.uk

 

 

“How Nanotech Could Reengineer Us.”

My personal thanks to kwolph, the unidentified fellow who was nice enough to stop by and forward me the link to this rather interesting infographic. Courtesy of the Keithley Center, which designs electronic systems for measurement and analysis, this infographic shows how advances in nanotechnology might aid us in reinventing and augmenting the human body.

These include augmenting our brain chemistry by either delivering drugs directly to our receptors (which can include anti-depressants, stimulants, or pain killers), or the more audacious approach of enhancing our thought pattens and memory by actively building and repairing neural tissue. As such, things like mental illness, brain injuries and trauma could be overcome at last.

In addition, there’s plenty of enhancing our hearts, lungs, reinforcing our bones, repairing muscle tissue, enhancing our eyes, reflexes, strength, endurance. And, as they point out, by virtue of the female model, the scourge of breast cancer, which effects one in eight women, could be be wiped out. No mother’s or young women dying before their time anymore!

And of course, other entirely too common ailments, heart disease, prostate cancer, ovarian cancer, lung cancer, and every form of degenerative disease, could be nipped in the bud either through regular maintenance of the bodily tissues, or by correcting the fault at the genetic level.

There’s really no limit to what programmable nanomachines could do, once the technology was realizable of course. And above all, proven to be safe and effective. And since it would mean that human beings no longer would be subject to disease or degenerative conditions (a la aging), lives could be extended indefinitely, which is part and parcel of the whole “transhuman”, “posthuman” and “postmortal” concept.

Naturally, they used the image of a very pretty young woman for the display. Had it been a man I’m guessing they would have gone with a six foot tall dude with washer board abs and only 1 percent body fat. Why can’t they ever use a porked out old dude with man boobs? That’s what I’d like to know? Well, for one, such regular individuals don’t exactly inspire confidence in the consumer market, do they?